EP2981258
LYFJAFRÆÐILEGAR EFNABLÖNDUR TIL AÐ GEFA FÚRÓSEMÍÐ UNDIR HÚÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.4.2014EP published:
12.8.2020EP application number:
14778339.3
EP translation filed:
13.10.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
2.4.2034Expiry date:
2.4.2026Next due date:
30.4.2026
Title:
PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE
Timeline
Today
3.4.2014EP application
12.8.2020EP Publication
13.10.2020Translation submitted
15.11.2020Registration published
2.4.2026Expires
Owner
Name:
scPharmaceuticals Inc.Address:
2400 District Avenue, Suite 310, Burlington, MA 01803, US
Inventor
Name:
MICHAELS, Scott, A.Address:
Boston, Massachusetts 02116, US
Name:
MUNTENDAM, PieterAddress:
Boston, Massachusetts 02116, US
Name:
LARSEN, Glenn, R.Address:
Boston, Massachusetts 02116, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361808962 PDate:
5.4.2013Country:
US
Classification
Categories:
A61K 31/341, A61K 9/00, A61K 47/02, A61K 47/18, A61K 9/08, A61K 31/635, A61P 9/12, A61P 9/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 18.3.2021
Expires: 2.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 21.3.2022
Expires: 2.4.2023
Payer: Patice ehf.
Number: 10
Paid: 21.3.2023
Expires: 2.4.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 2.4.2024
Expires: 2.4.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 14.3.2025
Expires: 2.4.2026
Payer: Árnason Faktor ehf.